Genetic and epigenetic changes of NKIRAS1 Gene in human renal cell carcinomas

Experimental Oncology

Volumn 32, Issue 2, 2010, Pages 71-75

  Gerashchenko, G V ^a   Bogatyrova, O O ^a   Rudenko, E E ^a   Kondratov, A G ^a   Gordiyuk, V V ^a   Zgonnyk, Y M ^b   Vozianov, O F ^b   Pavlova, T V ^c   Zabarovsky, E R ^c   Rynditch, A V ^a   Kashuba, V I ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chromosome 3; Genetic and epigenetic regulation; Methylation status; Quantitative real time PCR; Renal cell carcinoma

Indexed keywords

DNA; MESSENGER RNA; RAS PROTEIN; RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FEMALE; GENE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NKIRAS1 GENE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, RENAL CELL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954595520     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics. CA Cancer J Clin 2005; 55: 10-30.
2. Vogelzang NJ, Stadler WM. Kidney cancer. Lancet 1998; 352: 1691-6.
3. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-3.
4. Presti JC, Rao PH, Chen Q, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991; 51: 1544-52.
5. Linehan WM, Gnarra JR, Lerman MI, et al. Genetic basis of renal cell cancer. Important Adv Oncol 1993: 47-70.
6. Zhang YT, Chen N, Zeng H, et al. Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma. Zhonghua Bing Li Xue Za Zhi 2006; 35: 562-4 (In Chinese).
7. Kvasha S, Gordiyuk V, Kondratov A, et al. Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas. Cancer Lett 2008; 26: 250-7.
8. Angeloni D, ter Elst A, Wei MH, et al. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes. Genes Chromosomes Cancer 2006; 45: 676-91.
9. Kawai Y, Sakano S, Suehiro Y, et al. Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma. Ann Oncol 2009; doi: 10.1093/annonc/mdp577.
10. Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 987-9.
11. Gong K, Zhang N, Guo HF, et al. Frequent somatic mutations of the von Hippel-Lindau (VHL) tumor suppressor gene and its meaning in sporadic human renal clear cell carcinoma. Beijing Da Xue Xue Bao, 2004; 36: 169-72 (In Chinese).
12. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 2000; 50: 7-33.
13. Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001; 98: 9754-9.
14. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 2001; 158: 1639-51.
15. Skubitz KM, Zimmermann W, Kammerer R, et al. Differential gene expression identifies subgroups of renal cell carcinoma. J Lab Clin Med 2006; 147: 250-67.
16. Li J, Protopopov A, Wang F, et al. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A 2002; 99: 10724-9.
17. Skrypkina IYa, Kashuba VI, Gordiyuk VV, et al. Identification of changes in gene loci potentially associated with renal cancer by novel technique of NotI microarrays. Reports of the National Academy of Sciences of Ukraine 2006; 11: 188-192 (In Ukrainian).
18. Pavlova TV, Kashuba VI, Muravenko OV, et al. Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome. Mol Biol (Mosk) 2009; 43: 339-47 (In Russian).
19. Kashuba VI, Skripkina IIa, Saraev DV, et al. Identification of changes in gene loci potentially associated with cervical cancer using NotI microarrays. Ukr Biokhim Zh 2006; 78: 113-20 (In Russian).
20. Dieguez-Gonzalez R, Akar S, Calaza M, et al. Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis. Ann Rheum Dis 2009; 68: 579-83.
21. Escarcega RO, Fuentes-Alexandro S, García-Carrasco M, et al. The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol) 2007; 19: 154-61. (Pubitemid 46172840)
22. Lee HY, Youn SW, Kim JY, et al. FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappaB. Arterioscler Thromb Vasc Biol 2008; 28: 112-20.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9. (Pubitemid 17064313)
24. Herman JG, Graff JR, Myöhänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
25. Widschwendter M, Berger J, Müller HM, et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst 2000; 92: 826-32.
26. Jung M, Ramankulov A, Roigas J, et al. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol 2007; 8: 47.
27. Senchenko VN, Liu J, Loginov W, et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004; 23: 5719-28.
28. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
29. Ritz C and AN Spiess. qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysis. Bioinformatics 2008; 24: 1549-51.
30. Senchenko VN, Anedchenko EA, Kondratieva TT, et al. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer. BMC Cancer 2010; 10: 75.
31. Fenwick C, Na SY, Voll RE, et al. A subclass of Ras proteins that regulate the degradation of IkappaB. Science 2000; 287: 869-73. (Pubitemid 30084332)
32. Gerashchenko GV, Gordiyuk VV, Skrypkina IY, et al. Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer. Ukr Biokhim Zh 2009; 81: 81-7 (In Russian).